Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Indaptus Therapeutics, Inc. (INDP) had Weighted-Average Shares Outstanding (Diluted) of 0.57M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.23M |
|
-- |
|
-- |
|
$4.46M |
|
$-4.46M |
|
$-0.77M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-4.46M |
|
$-4.46M |
|
0.57M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.57M |
$-9.09 |
|
$-9.09 |
|
| Balance Sheet Financials | |
$6.41M |
|
-- |
|
$0.43M |
|
$6.84M |
|
$8.51M |
|
-- |
|
-- |
|
$8.51M |
|
$-1.67M |
|
$-1.67M |
|
$-1.67M |
|
0.60M |
|
| Cash Flow Statement Financials | |
$-9.07M |
|
-- |
|
$9.44M |
|
$5.79M |
|
$6.16M |
|
$0.37M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.75 |
|
-- |
|
-- |
|
-- |
|
-3.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
312.48% |
|
312.48% |
|
-76.46% |
|
312.48% |
|
$-2.77 |
|
$-15.77 |
|
$-15.77 |
|